Extremely short stature: influence of each parent's height on clinical-biological features
- PMID: 14646404
- DOI: 10.1159/000074244
Extremely short stature: influence of each parent's height on clinical-biological features
Abstract
Idiopathic extremely short stature probably has several causes.
Objective: To evaluate the influence of each parent's height on clinical-biological features.
Methods: 57 patients without intrauterine growth retardation seen at 7.9 +/- 0.4 years for height < or = -3 SD were classified according to the difference between their target height and actual height: < 2 SD in familial short stature (FSS, n = 28) and >2 SD in non-FSS (n = 29).
Results: Height decreased from -0.5 +/- 0.1 SD at birth to -2 +/- 0.2 SD at 1 year and -2.7 +/- 0.1 SD at 3 years, but the changes in the two groups were similar. FSS children were shorter than non-FSS children both at birth (p = 0.03) and as adults after growth hormone (GH) treatment (p < 0.05), but their plasma insulin-like growth factor I concentrations and GH peaks were similar. The FSS children fathers' heights were more frequently below -2 SD (64%) than the mothers' heights (35%) and were correlated with height at first evaluation (p < 0.05). For the whole population, the mothers' heights were correlated with birth weight (p < 0.05) and with height at first evaluation (p < 0.03).
Conclusion: This study confirms the influence of the mother's height on birth weight and shows how of the father's height influences idiopathic extremely short stature.
Copyright 2003 S. Karger AG, Basel
Similar articles
-
[Correlation between children's weight and height at medical examination on enrolling in 1st class of primary school and birth growth parameters with parental heights].Lijec Vjesn. 2006 Jan-Feb;128(1-2):13-9. Lijec Vjesn. 2006. PMID: 16640221 Croatian.
-
Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.J Clin Endocrinol Metab. 1999 May;84(5):1558-61. doi: 10.1210/jcem.84.5.5697. J Clin Endocrinol Metab. 1999. PMID: 10323379 Clinical Trial.
-
Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.J Clin Endocrinol Metab. 1996 Nov;81(11):3902-8. doi: 10.1210/jcem.81.11.8923836. J Clin Endocrinol Metab. 1996. PMID: 8923836
-
A new approach to the diagnosis of short stature.Minerva Pediatr. 2020 Aug;72(4):250-262. doi: 10.23736/S0026-4946.20.05835-1. Minerva Pediatr. 2020. PMID: 33045802 Review.
-
Evaluating short stature in children.Pediatr Ann. 2004 Mar;33(3):170-6. doi: 10.3928/0090-4481-20040301-08. Pediatr Ann. 2004. PMID: 15054931 Review.
Cited by
-
Skeletal age in idiopathic short stature: An analytical study by the TW3 method, Greulich and Pyle method.Indian J Orthop. 2010 Jul;44(3):322-6. doi: 10.4103/0019-5413.65144. Indian J Orthop. 2010. PMID: 20697487 Free PMC article.
-
The Auxological and Biochemical Continuum of Short Children Born Small for Gestational Age (SGA) or with Normal Birth Size (Idiopathic Short Stature).Int J Pediatr Endocrinol. 2010;2010:852967. doi: 10.1155/2010/852967. Epub 2010 May 18. Int J Pediatr Endocrinol. 2010. PMID: 20490349 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical